中华生物医学工程杂志
中華生物醫學工程雜誌
중화생물의학공정잡지
CHINESE JOURNAL OF BIOMEDICAL ENGINEERING
2011年
1期
48-52
,共5页
吴剑秋%马国建%李金田%李叔平%张元颖%刘德林%张晓梅
吳劍鞦%馬國建%李金田%李叔平%張元穎%劉德林%張曉梅
오검추%마국건%리금전%리숙평%장원영%류덕림%장효매
基因多态性%结直肠肿瘤%肿瘤转移%变性高效液相色谱%KAI1/CD82基因
基因多態性%結直腸腫瘤%腫瘤轉移%變性高效液相色譜%KAI1/CD82基因
기인다태성%결직장종류%종류전이%변성고효액상색보%KAI1/CD82기인
Polymorphism%Colorectal cancer%Metastasis%Denaturing high-performance liquid chromatoeraphy%KAI1/CD82
目的 研究肿瘤转移抑制基因KAII/CD82第8内含子IVS(8)6C11A/6T11G多态与结直肠癌发病及转移的相关性.方法 提取135例健康人、115例结直肠癌患者的外周血DNA,收集其相应的临床及病理资料,应用变性高效液相色谱技术,采用病例对照分组研究统计分析KAI1基因第8内含子剪接区域多态与结直肠癌发病及转移的相关性.结果 KAI1/CD82基因IVS(8)6T11G突变基因型检出率在正常人群为30.9%(84/135),结直肠癌患者中为31.3%(72/155),两者的差异无统计学意义(P=0.963);在结直肠癌低龄(<50岁)和高龄(≥50岁)患者之间以及性别之间差异均无统计学意义(均P>0.05);在常见的病理类型管状/管状乳头状腺癌、黏液腺癌中差异亦无统计学意义(P=0.633);在病理分级中有一定的差异性,但无统计学意义(P=0.267),而在有无淋巴结转移之间,两者差异有统计学意义(P.0.032)[6C11A有转移62.5%(80/128),无转移76.5%(78/102);6T11G有转移37.5%(48/128),无转移23.5%(24/102)].结论 肿瘤转移抑制基因KAI1/CD82第8内含子剪接区域多态与结直肠癌的发病、病理类型无关,但可能影响肿瘤的淋巴结转移,提示KAI1/CD82基因IVS(8)6C11A/6T11G多态筛查可能成为结直肠癌患者预后风险评估的指标.
目的 研究腫瘤轉移抑製基因KAII/CD82第8內含子IVS(8)6C11A/6T11G多態與結直腸癌髮病及轉移的相關性.方法 提取135例健康人、115例結直腸癌患者的外週血DNA,收集其相應的臨床及病理資料,應用變性高效液相色譜技術,採用病例對照分組研究統計分析KAI1基因第8內含子剪接區域多態與結直腸癌髮病及轉移的相關性.結果 KAI1/CD82基因IVS(8)6T11G突變基因型檢齣率在正常人群為30.9%(84/135),結直腸癌患者中為31.3%(72/155),兩者的差異無統計學意義(P=0.963);在結直腸癌低齡(<50歲)和高齡(≥50歲)患者之間以及性彆之間差異均無統計學意義(均P>0.05);在常見的病理類型管狀/管狀乳頭狀腺癌、黏液腺癌中差異亦無統計學意義(P=0.633);在病理分級中有一定的差異性,但無統計學意義(P=0.267),而在有無淋巴結轉移之間,兩者差異有統計學意義(P.0.032)[6C11A有轉移62.5%(80/128),無轉移76.5%(78/102);6T11G有轉移37.5%(48/128),無轉移23.5%(24/102)].結論 腫瘤轉移抑製基因KAI1/CD82第8內含子剪接區域多態與結直腸癌的髮病、病理類型無關,但可能影響腫瘤的淋巴結轉移,提示KAI1/CD82基因IVS(8)6C11A/6T11G多態篩查可能成為結直腸癌患者預後風險評估的指標.
목적 연구종류전이억제기인KAII/CD82제8내함자IVS(8)6C11A/6T11G다태여결직장암발병급전이적상관성.방법 제취135례건강인、115례결직장암환자적외주혈DNA,수집기상응적림상급병리자료,응용변성고효액상색보기술,채용병례대조분조연구통계분석KAI1기인제8내함자전접구역다태여결직장암발병급전이적상관성.결과 KAI1/CD82기인IVS(8)6T11G돌변기인형검출솔재정상인군위30.9%(84/135),결직장암환자중위31.3%(72/155),량자적차이무통계학의의(P=0.963);재결직장암저령(<50세)화고령(≥50세)환자지간이급성별지간차이균무통계학의의(균P>0.05);재상견적병리류형관상/관상유두상선암、점액선암중차이역무통계학의의(P=0.633);재병리분급중유일정적차이성,단무통계학의의(P=0.267),이재유무림파결전이지간,량자차이유통계학의의(P.0.032)[6C11A유전이62.5%(80/128),무전이76.5%(78/102);6T11G유전이37.5%(48/128),무전이23.5%(24/102)].결론 종류전이억제기인KAI1/CD82제8내함자전접구역다태여결직장암적발병、병리류형무관,단가능영향종류적림파결전이,제시KAI1/CD82기인IVS(8)6C11A/6T11G다태사사가능성위결직장암환자예후풍험평고적지표.
Objective To investigate the correlation of polymorphism of intron 8 (IVS-8) 6C11A /6T11G of metastasis suppressor gene KAI1/CD82 with the occurrence and metastasis of colorectal cancer.Methods From 135 healthy individuals and 115 patients with colorectal cancer, genomic DNA was extracted from peripheral blood, and their clinical data and pathological findings were retrieved.Correlation of the polymorphism at gene splicing region of the KAI1 IVS-8 with the occurrence and metastasis of colorectal cancer was analyzed in a case-control study by denaturing high-performance liquid chromatography (DHPLC) analysis.Results Mutant allelotype 6T11G of KAI1/CD82 gene IVS-8 was detected in 30.9% of healthy individuals (84/135) and 31.3% of colorectal cancer patients (72/155) , with no significant difference between the two groups (P=0.963).The genotypes did not differ between younger (<50 years) and older patients (=50 years) (P>0.05), between male and female(P>0.05), or among common pathological types including tubular or tubulopapillary adenocarcinoma and mucinous adenocarcinoma (P=0.633).The prevalence of genotypes differed among pathological stages, but without statistical significance (P=0.267).However, a statistical difference was shown between patients with and without lymph node invasion [6C11A detected in 62.5% vs 76.5% of patients with (80/128) and without metastases (78/102); 6T11G detected in 37.5% vs 23.5% of patients with (48/128) and without metastases (24/102) ; (P=0.032) ].Conclusion The genetic polymorphism of IVS-8 in KAI1/CD82 gene may not be related with occurrence, pathological types of colorectal cancer but may play a role in lymph node metastasis, implicating that screening of 6C11A /6T11G polymorphism can be used to identify the prognosis of colorectal cancer patients.